Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Apr 1;183(4):1917-21.
doi: 10.1084/jem.183.4.1917.

Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy

S Valitutti  1 , S Müller, M Dessing, A Lanzavecchia
Affiliations

Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy

S Valitutti et al. J Exp Med. .

Abstract

We have investigated the level of TCR occupancy required to elicit different biological responses in human CTL clones specific for an influenza matrix peptide. Specific cytotoxicity could be detected at extremely low peptide concentrations (10(-12) to 10(-15) M). However, IFN-gamma production, responsiveness to IL-2 and Ca++ fluxes were observed only at peptide concentrations > 10(-9) M, while autonomous proliferation required even higher peptide concentrations. In parallel experiments we measured TCR downregulation to estimate the number of TCRs triggered. We observed that at low peptide concentrations, where only cytotoxicity is triggered, TCR downregulation was hardly detectable. Conversely, induction of IFN-gamma production and proliferation required triggering of at least 20-50% of TCRs. Taken together these results indicate that a single CTL can graduate different biological responses as a function of antigen concentration and that killing of the specific target does not necessarily result in full activation.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Exp Med. 1979 Nov 1;150(5):1134-42 - PubMed
    1. Nature. 1995 May 11;375(6527):148-51 - PubMed
    1. Eur J Immunol. 1988 Feb;18(2):219-23 - PubMed
    1. J Exp Med. 1988 Dec 1;168(6):2045-57 - PubMed
    1. Nature. 1990 Aug 9;346(6284):574-6 - PubMed

Publication types

MeSH terms